Donald L. Hagan, LLC Pfizer Inc Transaction History

Donald L. Hagan, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	SELL	$41.32 - $61.25 $326,510 - $483,997	-7,902 Closed	0 $0
Q3 2021 Oct 20, 2021	SELL	$39.25 - $50.42 $313,843 - $403,158	-7,996 Reduced 50.3%	7,902 $340,000
Q2 2021 Jul 19, 2021	BUY	$35.91 - $40.68 $3,267 - $3,701	91 Added 0.58%	15,898 $623,000
Q1 2021 Apr 27, 2021	SELL	$33.49 - $37.77 $10,482 - $11,822	-313 Reduced 1.94%	15,807 $573,000
Q4 2020 Jan 15, 2021	SELL	$33.47 - $42.56 $97,297 - $123,721	-2,907 Reduced 15.28%	16,120 $593,000
Q3 2020 Oct 16, 2020	SELL	$31.75 - $37.25 $288,766 - $338,788	-9,095 Reduced 32.34%	19,027 $698,000
Q2 2020 Aug 03, 2020	SELL	$30.12 - $36.54 $129,094 - $156,610	-4,286 Reduced 13.23%	28,122 $920,000
Q1 2020 Apr 17, 2020	BUY	$27.03 - $38.62 $875,988 - $1.25 Million	32,408 New	32,408 $1.17 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Donald L. Hagan, LLC, based on Form 13F filings with the SEC.

Stay updated on Donald L. Hagan, LLC with notifications on news.